4//SEC Filing
RICHMOND MARK 4
Accession 0001209191-05-032582
CIK 0000729922other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 3:54 PM ET
Size
12.5 KB
Accession
0001209191-05-032582
Insider Transaction Report
Form 4
RICHMOND MARK
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2005-06-16−1,500→ 24,500 totalExercise: $16.81From: 2000-04-10Exp: 2010-04-09→ Common Stock (1,500 underlying) - Exercise/Conversion
Common Stock
2005-06-16$16.81/sh+1,500$25,220→ 5,075 total - Sale
Common Stock
2005-06-16$40.00/sh−1,500$60,000→ 3,575 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Exercisable as to 25,000 shares on 04/10/2000 and the remainder on 04/10/2001.
- [F3]The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3.
- [F4]Includes only options with the same termination date.
Issuer
OSI PHARMACEUTICALS INC
CIK 0000729922
Entity typeother
Related Parties
1- filerCIK 0001238971
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 3:54 PM ET
- Size
- 12.5 KB